Ketamine has recognised medical uses, but the risks change significantly when it is used frequently or obtained outside regulated healthcare. The main concerns include dependence, bladder and urinary damage, abdominal and liver-related complications, impaired judgement and uncertainty about the identity or strength of unregulated products. Medical ketamine treatment and non-medical use should not be treated as the same thing.
Ketamine occupies an unusual position in medicine and public health. It is a legitimate medicine used in human and veterinary care, but it is also used outside medical settings, where the risks can be very different.
That distinction matters because the word “ketamine” can describe several very different situations. A patient receiving ketamine under clinical supervision is dealing with a known medicine, a controlled dose and medical monitoring. Someone obtaining a substance through an unregulated source may not know with the same confidence what the product contains, how concentrated it is, or whether claims about its quality are accurate.
In the UK, ketamine remains a Class B controlled drug. It also continues to have recognised medical uses, including anaesthesia and pain management, while esketamine has a licensed role in treatment-resistant depression. The Advisory Council on the Misuse of Drugs published an updated review of ketamine use and harms in January 2026, confirming both its legitimate medical role and the growing concerns around frequent non-medical use.
This guide explains those differences without treating all ketamine use as though it were the same thing.
Ketamine at a glance
| Drug type | Dissociative anaesthetic |
|---|---|
| UK legal status | Class B controlled drug |
| Recognised medical uses | Anaesthesia and pain management; esketamine also has a licensed role in treatment-resistant depression |
| Main longer-term concerns | Dependence, bladder and urinary damage, abdominal complications, and liver or biliary problems |
What is ketamine?
Ketamine is a dissociative anaesthetic. Doctors have used it for decades because it can produce anaesthesia and pain relief while affecting consciousness and perception in ways that differ from many conventional sedatives.
The term “dissociative” refers to the sense of separation that ketamine can produce between awareness, the body and the surrounding environment. At medically controlled doses, clinicians use those effects deliberately. Outside medical supervision, the same effects can become unpredictable and may contribute to confusion, impaired coordination, altered judgement or a profound sense of detachment from the surrounding environment.
Ketamine is used in both human and veterinary medicine. The ACMD’s 2026 review describes ketamine as an established dissociative anaesthetic and analgesic and also discusses its more recent role in the management of treatment-resistant depression.
That medical history is important because describing ketamine simply as a “street drug” does not tell the whole story. The substance itself has legitimate clinical value. The setting, product, frequency of exposure and level of medical supervision make a substantial difference to the risks involved.
How does ketamine work?
Ketamine affects several signalling systems in the nervous system, although its activity at NMDA receptors is particularly important.
These receptors normally respond to glutamate, one of the brain’s major signalling chemicals. By altering NMDA receptor activity, ketamine can affect perception, pain processing, memory and consciousness.
The result is not identical at every exposure level. Depending on the clinical context and amount involved, the effects can range from pain relief and sedation to marked dissociation and substantial changes in awareness.
This variability is one reason medical use involves assessment and monitoring rather than treating ketamine as an ordinary medicine with one predictable effect in every person.
What is ketamine used for medically?
Ketamine has long been used as an anaesthetic and analgesic. It can be particularly useful in situations where clinicians require rapid pain control or anaesthesia.
More recently, ketamine and its related compound esketamine have received considerable attention in psychiatry.
Esketamine is one of the two mirror-image forms of ketamine. A nasal-spray preparation is licensed for certain adults with treatment-resistant major depressive disorder. NICE describes its authorised use alongside an SSRI or SNRI in adults who have not responded to at least two antidepressant treatments during the current moderate-to-severe depressive episode. You can read the NICE information about esketamine here.
That does not mean esketamine is routinely recommended through the NHS. NICE currently states that esketamine nasal spray is not recommended for treatment-resistant depression within its technology appraisal guidance. The recommendation remains unchanged. See the NICE depression guidance.
This distinction matters because “ketamine treatment” is often discussed online as though it were one standard service. In reality, formulations, clinical indications, treatment settings and access routes differ considerably.
For a fuller explanation, see our Medical Ketamine: Treatment, Uses and UK Access guide.
Medical ketamine and unregulated ketamine are not interchangeable
A medicine administered in a hospital or regulated clinic comes with information and safeguards that may be absent when a substance comes from an unregulated source.
Clinicians know the active ingredient, concentration and formulation they are administering. They can also take account of a patient’s medical history and monitor relevant clinical effects during treatment.
None of those safeguards can automatically be assumed when a substance is obtained outside legitimate healthcare channels.
Medical ketamine and unregulated ketamine: key differences
| Medical use | Unregulated use |
|---|---|
| Known medicine and formulation | Identity and composition may be uncertain |
| Known concentration and dose | Strength may not be independently verified |
| Clinical assessment before treatment | No automatic medical assessment |
| Monitoring during treatment | No clinical monitoring |
| Documented storage and handling | Origin and handling may be unknown |
Descriptions such as “medical grade”, “pharmaceutical grade”, “pure” or “99%” may sound reassuring, but a seller’s description is not the same thing as independent verification.
This becomes particularly important when people try to judge an unknown substance from photographs, colour, crystal size or texture. Those characteristics do not reliably establish chemical identity, concentration or purity.
Our Forms of Ketamine guide explains the difference between recognised pharmaceutical terminology and informal descriptions such as rock, raw and sugar ketamine.
What effects can ketamine produce?
The effects of ketamine can vary substantially depending on the circumstances in which it is used.
The ACMD’s updated harms review describes acute effects that can include impaired coordination, hallucinations, agitation, abnormal movements and reduced consciousness. More severe intoxication can involve significant changes in pulse or blood pressure, prolonged sedation, respiratory problems or convulsions.
One of ketamine’s better-known effects is dissociation. A person may feel disconnected from their body or surroundings, and at greater levels of intoxication that experience can become profound.
That altered awareness can create risks beyond the direct effects of the drug itself. Someone who is heavily dissociated may be less able to respond appropriately to traffic, water, heights or other hazards.
The important point is that the experience cannot be reduced to whether someone simply “feels high”. Loss of coordination and situational awareness can be just as significant.
What are the longer-term risks?
The clearest concern with repeated ketamine use is that some harms become more likely as exposure becomes frequent or prolonged.
The UK’s 2026 review identifies dependence and significant complications involving the bladder and urinary tract, kidneys, abdomen, liver and bile ducts among the harms associated with longer-term use.
These problems are not theoretical. Some can become severe enough to require specialist medical treatment.
Bladder and urinary damage
Ketamine-related bladder disease has become one of the most recognised complications of frequent use.
Symptoms can include needing to urinate much more often, waking repeatedly during the night, urgency, pain when urinating, blood in the urine, leakage and bladder pain. The ACMD review discusses the increasing clinical burden associated with ketamine-related urinary problems.
This matters because people may dismiss early symptoms as a simple urinary infection or tolerate them until the problem becomes much harder to ignore.
Persistent urinary pain, blood in the urine or a marked increase in urinary frequency deserves medical assessment.
Read our dedicated guide to ketamine safety and harm reduction for a broader explanation of longer-term health risks.
Abdominal pain and “K-cramps”
Regular ketamine use has also been associated with severe abdominal pain, sometimes accompanied by nausea or vomiting.
These episodes are often referred to informally as “K-cramps”, although that name can make the problem sound less serious than it may be.
The ACMD review describes chronic abdominal pain among regular users and also discusses hepatobiliary complications associated with prolonged ketamine exposure.
Repeated or severe abdominal pain should therefore not automatically be treated as an expected inconvenience of ketamine use.
Liver and bile-duct complications
Frequent ketamine exposure can also affect the liver and biliary system.
The 2026 ACMD review describes abnormal liver function and bile-duct abnormalities in some people with prolonged or heavy exposure. This area receives less public attention than bladder damage, which can make it easier for people to overlook symptoms or fail to connect them with ketamine use.
Can people become dependent on ketamine?
Yes. Ketamine can produce dependence, particularly where use becomes frequent.
The ACMD has reported increasing recognition of ketamine use disorder among people who consume the drug regularly and in larger amounts. Withdrawal symptoms may also occur when someone stops after heavy or sustained use, although the evidence base for managing ketamine withdrawal is less developed than it is for some other substances.
Dependence does not necessarily begin with an obvious point at which someone decides to use every day. It may develop gradually as tolerance increases and occasional use becomes more frequent.
Possible warning signs include needing more of the substance to produce the same effect, using more frequently than intended, continuing despite urinary or abdominal symptoms, and finding it increasingly difficult to reduce use.
For more information, see our Ketamine Safety and Harm Reduction section.
What about memory and cognition?
Research into the long-term cognitive effects of ketamine is more complicated than some online claims suggest.
Observational studies cannot always separate the effect of ketamine from other factors such as additional substance use, sleep disruption, mental health conditions or lifestyle.
Even with those limitations, the ACMD’s review concludes that chronic, frequent or high-level illicit use may impair aspects of cognitive functioning. Some evidence also suggests that at least part of this effect may improve after exposure stops.
The sensible interpretation is therefore neither to exaggerate certainty nor to dismiss the potential risk because every mechanism has not been completely established.
What forms does ketamine come in?
In clinical settings, ketamine is supplied as a pharmaceutical preparation with a known formulation and concentration.
Outside regulated healthcare, the terminology becomes much less precise.
People may encounter descriptions such as:
- ketamine powder
- ketamine crystals
- liquid ketamine
- ketamine salt
- rock ketamine
- raw ketamine
- sugar ketamine
Some of these terms describe a physical appearance, while others are informal market language rather than recognised pharmaceutical categories.
Ketamine hydrochloride, for example, is a genuine chemical form. Terms such as “sugar ketamine” or “rock ketamine” do not provide the same kind of scientific information about what a product contains.
A white crystalline appearance does not prove that a substance is ketamine, and texture alone does not establish purity.
See Forms of Ketamine: Powder, Crystal, Liquid, Salt and Other Terms Explained for a detailed breakdown.
Is ketamine legal in the UK?
Ketamine is currently a Class B controlled drug in the United Kingdom.
The Advisory Council on the Misuse of Drugs reviewed ketamine’s classification again during 2025 and 2026 after the government asked whether it should be moved to Class A. In January 2026, the ACMD advised that ketamine should remain Class B. See the ACMD classification announcement.
That classification does not prevent legitimate medical use, but possession or supply outside lawful circumstances can amount to a criminal offence.
According to current GOV.UK drug penalty guidance, the maximum penalty for possession of a Class B controlled drug can be up to five years in prison, an unlimited fine, or both. Supply and production can carry a maximum sentence of up to fourteen years, an unlimited fine, or both.
For a fuller explanation of possession, supply and legitimate medical use, see Ketamine Law in the UK.
Why has ketamine received more attention in the UK?
The pattern of ketamine use in the UK has changed substantially over the past decade.
The ACMD’s 2026 review describes increasing use among younger people alongside growing evidence of high-frequency use, dependence and related medical complications. It also reports increases in the number of people presenting to treatment services with ketamine-related problems.
That change matters because public discussion still sometimes reflects an older image of ketamine as an occasional club drug.
For some people, the current pattern looks very different. Frequent use can involve dependence, bladder symptoms, abdominal pain and disruption to work, education or relationships.
Recognising that pattern early may make it easier to seek help before complications become more difficult to manage.
Is ketamine used to treat depression?
Ketamine has generated substantial interest because its antidepressant effects appear to differ from those of conventional antidepressants.
However, there is an important distinction between clinical research, specialist prescribing, licensed esketamine treatment and people attempting to self-treat depression with ketamine obtained outside healthcare.
The fact that a substance has therapeutic potential does not make unsupervised use equivalent to treatment.
Clinical care involves assessment, patient selection, consideration of other medicines and health conditions, controlled administration and appropriate monitoring.
Someone experiencing depression who is interested in ketamine or esketamine treatment should therefore approach it as a healthcare question rather than a product-purchasing question.
Our Medical Ketamine guide explains the treatment landscape in more detail.
What if someone is thinking about buying ketamine online?
The first issue is not which seller appears more convincing.
It is whether the buyer can independently establish what is actually being supplied.
An online listing may contain photographs, customer comments, laboratory claims or statements about purity, but those things do not necessarily establish the identity or concentration of the material that eventually arrives.
The ACMD’s review of ketamine harms discusses risks associated with illicit supply, uncertain purity and adulteration.
There is also the UK legal position to consider.
For those reasons, our Buy Ketamine Online UK: Risks, Legality and What to Know page focuses on the issues people should understand before making a decision rather than directing readers to sellers.
When should someone seek medical help?
People should not wait for symptoms to become unbearable before speaking to a healthcare professional.
Repeated urinary urgency, pain when passing urine, blood in the urine, bladder pain or persistent abdominal symptoms can be associated with ketamine-related complications.
Early assessment matters because some complications can become more difficult to manage after prolonged exposure.
Severe loss of consciousness, seizures, serious breathing problems or any other medical emergency following substance use require urgent medical attention.
People concerned about dependence can also speak with a GP or local drug and alcohol treatment service.
The important distinction
Ketamine is not accurately described as simply a dangerous illicit drug, nor is it accurate to treat it as harmless because it has legitimate medical uses.
It is a clinically useful medicine with recognised applications, while repeated or uncontrolled use can cause substantial harm.
That distinction runs through this entire site.
When ketamine is used medically, clinicians know what substance they are administering, why they are using it and how the patient is responding. Outside that environment, uncertainty about product identity, exposure and health effects can change the risk considerably.
Understanding those differences is more useful than either exaggerating the dangers or minimising them.
References
- Advisory Council on the Misuse of Drugs: Ketamine – an updated review of use and harms
- Ketamine: updated review of use and harms – accessible version
- ACMD decision on the classification of ketamine
- GOV.UK: Drug possession, supply and production penalties
- NICE: Information about esketamine for treatment-resistant depression
- NICE: Depression in adults – recommendations
